Clinical Trial Update: A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on the completed Phase 1/2 trial of SB1518 for advanced myeloid malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelofibrosis
• Myelogenous Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• SB1518

Snippet

Sponsor: S*BIO | Conditions: Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia | Phase 1, Phase 2 | Status: COMPLETED